Vaccine

The Global Health Innovative Technology Fund has awarded $3.2 million to UF, and partners in the U.S. and Japan, to advance a promising vaccine for malaria transmission prevention.

Study findings could aid in interrupting transmission chains and reducing severe illness

A commentary published this week in one of the world’s premier journals on vaccination raises concerns about the CDC’s recommendation against using the popular “FluMist” vaccine during the 2016 – 2017 flu season.

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

Hurricane Matthew’s sweep through southern Haiti last October killed hundreds; left nearly 200,000 without homes; and flooded rivers, latrines and wells, contaminating drinking water and prompting reports of increasing cholera cases in the hardest hit areas of the nation.

when the Ebola crisis in West Africa began capturing the world’s attention, UF biostatistics professor Ira Longini has been collaborating with a team of scientists at the World Health Organization (WHO) to develop a vaccine capable of protecting the most at-risk populations from the disease.

The waning number of Ebola cases is good news for West Africa, but for those developing a vaccine for the disease, it means time is running short.

Recently, University of Florida Health researchers discovered why an influenza virus was making young people admitted to UF Health Shands Hospital so sick: It contained a mutation that allowed it to infect the patients’ lower respiratory tracts.

Mathematical models predicted it, and now a University of Florida study confirms it: Immunizing school-aged children from flu can protect other segments of the population, as well.